Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Oct-23 6:50 PM View:  | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 18-Oct-23 | Sale | 386,350 | $0.01 | $4,249.85 | (3%) 12.13M to 11.75M | |
| 20-May-22 5:57 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 20-May-22 | Purchase | 545,488 | $2.23 | $1,215,350.00 | 5% 11.59M to 12.13M | |
| 20-May-22 5:57 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 19-May-22 | Purchase | 323,808 | $2.19 | $707,844.00 | 3% 11.26M to 11.59M | |
| 20-May-22 5:57 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 18-May-22 | Private Purchase | 173,700 | $1.96 | $340,799.00 | 2% 11.09M to 11.27M | |
| 15-Mar-22 6:23 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 11-Mar-22 | Market Purchase | 1,000,000 | $3.00 | $3,000,000.00 | 10% 10.09M to 11.09M | 5% |
| 14-Mar-22 4:37 PM View: | Kilcoyne Adrian Chief Medical Officer | KaloBios Pharmaceuticals, I... (HGEN) | 09-Mar-22 | Purchase | 5,000 | $2.78 | $13,900.00 | 71% 7.0K to 12.0K | |
| 14-Mar-22 4:37 PM View: | Kilcoyne Adrian Chief Medical Officer | KaloBios Pharmaceuticals, I... (HGEN) | 08-Mar-22 | Private Purchase | 7,000 | $2.53 | $17,710.00 | 100% 0 to 7.0K | |
| 04-Mar-22 6:05 AM View: | Edward P. Jordan Chief Commercial Officer | KaloBios Pharmaceuticals, I... (HGEN) | 02-Mar-22 | Private Purchase | 12,500 | $2.32 | $29,000.00 | 100% 0 to 12.5K | |
| 04-Mar-22 6:06 AM View: | Durrant Cameron Chief Executive Officer Director | KaloBios Pharmaceuticals, I... (HGEN) | 02-Mar-22 | Private Purchase | 40,000 | $2.34 | $93,600.00 | 133% 30.0K to 70.0K | |
| 13-Aug-21 9:28 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 12-Aug-21 | Market Sale | 57,551 | $17.16 | $987,564.00 | (< 1%) 10.18M to 10.12M | (2%) |
| 13-Aug-21 9:28 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 11-Aug-21 | Market Sale | 109,647 | $17.07 | $1,872,150.00 | (1%) 10.29M to 10.18M | (3%) |
| 30-Jul-21 9:01 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 29-Jul-21 | Market Sale | 29,394 | $17.03 | $500,703.00 | (< 1%) 10.29M to 10.26M | 3% |
| 30-Jul-21 9:01 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 28-Jul-21 | Market Sale | 9,692 | $17.04 | $165,162.00 | (< 1%) 10.3M to 10.29M | 3% |
| 23-Jul-21 8:32 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 23-Jul-21 | Market Sale | 5,584 | $17.04 | $95,154.70 | (< 1%) 10.3M to 10.3M | < 1% |
| 23-Jul-21 8:32 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 22-Jul-21 | Market Sale | 178,005 | $17.04 | $3,032,800.00 | (2%) 10.48M to 10.3M | < 1% |
| 23-Jul-21 8:32 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 21-Jul-21 | Market Sale | 132,764 | $17.14 | $2,275,120.00 | (1%) 10.61M to 10.48M | < 1% |
| 16-Jul-21 8:28 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 14-Jul-21 | Market Sale | 15,177 | $17.06 | $258,847.00 | (< 1%) 10.63M to 10.61M | 2% |
| 09-Jul-21 9:01 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 09-Jul-21 | Market Sale | 296,036 | $17.37 | $5,142,770.00 | (3%) 10.93M to 10.63M | 4% |
| 09-Jul-21 9:01 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 08-Jul-21 | Market Sale | 48,010 | $17.17 | $824,111.00 | (< 1%) 10.97M to 10.93M | 3% |
| 02-Jul-21 10:00 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 02-Jul-21 | Market Sale | 102,848 | $17.12 | $1,760,760.00 | (< 1%) 11.08M to 10.97M | < 1% |
| 02-Jul-21 10:00 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 01-Jul-21 | Market Sale | 140,992 | $17.10 | $2,410,670.00 | (1%) 11.22M to 11.08M | < 1% |
| 02-Jul-21 10:00 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 30-Jun-21 | Market Sale | 219,256 | $17.28 | $3,787,950.00 | (2%) 11.44M to 11.22M | 1% |
| 25-Jun-21 9:01 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 25-Jun-21 | Market Sale | 1,000,000 | $17.80 | $17,803,500.00 | (8%) 12.44M to 11.44M | (3%) |
| 25-Jun-21 9:01 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 24-Jun-21 | Market Sale | 139,529 | $18.37 | $2,563,830.00 | (1%) 12.58M to 12.44M | (< 1%) |
| 25-Jun-21 9:01 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 23-Jun-21 | Market Sale | 133,126 | $18.28 | $2,434,180.00 | (1%) 12.71M to 12.58M | (< 1%) |
| 21-Jun-21 8:57 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 18-Jun-21 | Market Sale | 402,480 | $18.50 | $7,445,560.00 | (3%) 13.11M to 12.71M | 2% |
| 21-Jun-21 8:57 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 17-Jun-21 | Market Sale | 181,423 | $19.17 | $3,478,440.00 | (1%) 13.29M to 13.11M | 5% |
| 21-Jun-21 8:57 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 16-Jun-21 | Market Sale | 158,486 | $19.41 | $3,076,190.00 | (1%) 13.45M to 13.29M | 6% |
| 16-Jun-21 9:40 PM View: | Durrant Cameron Chief Executive Officer Director | KaloBios Pharmaceuticals, I... (HGEN) | 14-Jun-21 | Market Sale | 81,441 | $20.64 | $1,680,930.00 | (73%) 111.44K to 30.0K | |
| 09-Jun-21 5:10 PM View: | Edward P. Jordan Chief Commercial Officer | KaloBios Pharmaceuticals, I... (HGEN) | 08-Jun-21 | Market Option Sale | 14,700 | $20.08 | $295,176.00 | (100%) 14.7K to 0 | |
| 09-Jun-21 5:10 PM View: | Edward P. Jordan Chief Commercial Officer | KaloBios Pharmaceuticals, I... (HGEN) | 08-Jun-21 | Option Exercise | 14,700 | $9.65 | $141,855.00 | 100% 0 to 14.7K | |
| 09-Jun-21 4:45 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 07-Jun-21 | Market Sale | 80,636 | $19.08 | $1,538,790.00 | (< 1%) 13.53M to 13.45M | (8%) |
| 04-Jun-21 6:07 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 04-Jun-21 | Market Sale | 127,084 | $18.46 | $2,346,420.00 | (< 1%) 13.66M to 13.53M | 1% |
| 04-Jun-21 6:07 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 03-Jun-21 | Market Sale | 191,154 | $18.37 | $3,511,310.00 | (1%) 13.85M to 13.66M | < 1% |
| 04-Jun-21 6:07 PM View: | Chappell Dale Chief Scientific Officer Director 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 02-Jun-21 | Market Sale | 76,126 | $19.01 | $1,447,270.00 | (< 1%) 13.93M to 13.85M | 4% |
| 11-Mar-21 8:24 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 11-Mar-21 | Disposition (other) | 37,912 | $15.49 | $587,257.00 | (< 1%) 5.5M to 5.46M | (6%) |
| 11-Mar-21 8:24 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 11-Mar-21 | Market Sale | 119,201 | $16.02 | $1,909,670.00 | (2%) 5.46M to 5.34M | (3%) |
| 11-Mar-21 8:24 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 10-Mar-21 | Market Sale | 32,469 | $16.46 | $534,589.00 | (< 1%) 5.53M to 5.5M | < 1% |
| 11-Mar-21 8:24 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 09-Mar-21 | Market Sale | 83,568 | $17.24 | $1,440,500.00 | (< 1%) 55.72M to 55.63M | 5% |
| 16-Jun-21 9:40 PM View: | Durrant Cameron Chief Executive Officer Director | KaloBios Pharmaceuticals, I... (HGEN) | 01-Mar-21 | Gift | 111,441 | -- | -- | 100% 111.44K to 222.88K | |
| 16-Jun-21 9:40 PM View: | Durrant Cameron Chief Executive Officer Director | KaloBios Pharmaceuticals, I... (HGEN) | 01-Mar-21 | Gift | 111,441 | -- | -- | (50%) 222.88K to 111.44K | |
| 01-Mar-21 5:48 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 01-Mar-21 | Market Sale | 14,100 | $18.65 | $262,951.00 | (< 1%) 5.63M to 5.62M | < 1% |
| 01-Mar-21 5:48 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 26-Feb-21 | Market Sale | 30,003 | $19.18 | $575,437.00 | (< 1%) 5.66M to 5.63M | 3% |
| 01-Mar-21 5:48 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 25-Feb-21 | Market Sale | 2,402 | $19.17 | $46,044.90 | (< 1%) 5.66M to 5.66M | 3% |
| 24-Feb-21 6:27 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 24-Feb-21 | Market Sale | 25,906 | $19.55 | $506,333.00 | (< 1%) 5.69M to 5.66M | 4% |
| 24-Feb-21 6:27 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 22-Feb-21 | Market Sale | 77,314 | $23.21 | $1,794,690.00 | (1%) 5.77M to 5.69M | 19% |
| 19-Feb-21 6:02 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 19-Feb-21 | Market Sale | 37,300 | $23.50 | $876,364.00 | (< 1%) 5.8M to 5.77M | 8% |
| 19-Feb-21 6:02 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 18-Feb-21 | Market Sale | 42,408 | $21.69 | $920,042.00 | (< 1%) 5.85M to 5.8M | < 1% |
| 19-Feb-21 6:02 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 17-Feb-21 | Market Sale | 9,700 | $19.92 | $193,214.00 | (< 1%) 5.86M to 5.85M | (9%) |
| 16-Feb-21 6:53 PM View: | Nomis Bay Ltd. 10% Owner | KaloBios Pharmaceuticals, I... (HGEN) | 13-Feb-21 | Market Sale | 16,423 | $19.68 | $323,221.00 | (< 1%) 5.87M to 5.86M | (2%) |
